$VBIV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VBI Vaccines Inc/BC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VBI Vaccines Inc/BC. Get notifications about new insider transactions in VBI Vaccines Inc/BC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | A | 3.15 | 75,000 | 236,250 | 75,000 | |
| Feb 01 2021 | VBIV | VBI Vaccines Inc/B ... | Mazaltov Avi | Head Global MFG&GM- ... | Option Exercise | A | 3.14 | 500,000 | 1,570,000 | 500,000 | |
| Feb 01 2021 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | A | 3.15 | 75,000 | 236,250 | 75,000 | |
| Feb 01 2021 | VBIV | VBI Vaccines Inc/B ... | Mazaltov Avi | Head Global MFG&GM- ... | Option Exercise | A | 3.14 | 500,000 | 1,570,000 | 500,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | McKee Blaine H. | Director | Option Exercise | A | 3.15 | 75,000 | 236,250 | 75,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Option Exercise | A | 3.14 | 500,000 | 1,570,000 | 500,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | Braga Damian | Director | Option Exercise | A | 3.15 | 75,000 | 236,250 | 75,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | A | 3.15 | 500,000 | 1,575,000 | 500,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Option Exercise | A | 3.15 | 500,000 | 1,575,000 | 500,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | Cordeiro Joanne | Director | Option Exercise | A | 3.15 | 75,000 | 236,250 | 75,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | A | 3.15 | 500,000 | 1,575,000 | 500,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 3.15 | 100,000 | 315,000 | 100,000 | |
| Jan 29 2021 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | A | 3.15 | 1,000,000 | 3,150,000 | 1,000,000 | |
| Jul 02 2020 | VBIV | VBI Vaccines Inc/B ... | Mazaltov Avi | Head Global MFG&GM- ... | Option Exercise | A | 2.99 | 167,150 | 499,779 | 167,150 | |
| Jul 02 2020 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Option Exercise | A | 2.99 | 167,150 | 499,779 | 167,150 | |
| Jul 02 2020 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | A | 2.94 | 425,200 | 1,250,088 | 425,200 | |
| Jul 02 2020 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | A | 2.94 | 170,100 | 500,094 | 170,100 | |
| Jul 02 2020 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | A | 2.94 | 170,100 | 500,094 | 170,100 | |
| Jul 02 2020 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Option Exercise | A | 2.94 | 170,100 | 500,094 | 170,100 | |
| Apr 28 2020 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.10 | 9,090,909 | 10,000,000 | 55,042,456 | 46 M to 55 M (+19.78 %) |
| Mar 24 2020 | VBIV | VBI Vaccines Inc/B ... | Braga Damian | Director | Option Exercise | A | 0.81 | 250,000 | 202,500 | 250,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Option Exercise | A | 1.46 | 350,000 | 511,000 | 350,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 1.46 | 350,000 | 511,000 | 350,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | McKee Blaine H. | Director | Option Exercise | A | 1.46 | 250,000 | 365,000 | 250,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | Mazaltov Avi | Head Global MFG&GM- ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | A | 1.46 | 350,000 | 511,000 | 350,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Option Exercise | A | 1.66 | 350,000 | 581,000 | 350,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | Cordeiro Joanne | Director | Option Exercise | A | 1.46 | 250,000 | 365,000 | 250,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | A | 1.46 | 500,000 | 730,000 | 500,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | A | 1.46 | 250,000 | 365,000 | 250,000 | |
| Jan 24 2020 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | A | 1.46 | 350,000 | 511,000 | 350,000 | |
| Oct 07 2019 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 0.50 | 40,000 | 20,000 | 117,500 | 77.5 K to 117.5 K (+51.61 %) |
| Oct 07 2019 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 0.50 | 14,500 | 7,250 | 14,500 | 0 to 14.5 K |
| Oct 01 2019 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Buy | P | 0.47 | 12,000 | 5,676 | 37,000 | 25 K to 37 K (+48.00 %) |
| Oct 01 2019 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Buy | P | 0.48 | 10,000 | 4,822 | 60,000 | 50 K to 60 K (+20.00 %) |
| Sep 30 2019 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 0.50 | 150,000 | 75,450 | 608,255 | 458.3 K to 608.3 K (+32.73 %) |
| Sep 24 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.50 | 20,000,000 | 10,000,000 | 45,951,556 | 26 M to 46 M (+77.07 %) |
| Jul 01 2019 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 1.07 | 8,000 | 8,560 | 77,500 | 69.5 K to 77.5 K (+11.51 %) |
| Jun 20 2019 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 0.89 | 42,000 | 37,380 | 69,500 | 27.5 K to 69.5 K (+152.73 %) |
| Jun 20 2019 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 0.78 | 10,000 | 7,800 | 27,500 | 17.5 K to 27.5 K (+57.14 %) |
| Jun 20 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.65 | 1,000,000 | 650,000 | 25,951,556 | 25 M to 26 M (+4.01 %) |
| Jun 19 2019 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Buy | P | 0.74 | 8,000 | 5,886 | 50,000 | 42 K to 50 K (+19.05 %) |
| Jun 19 2019 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 0.73 | 144,000 | 105,336 | 458,255 | 314.3 K to 458.3 K (+45.82 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | M | 0.00 | 31,250 | 0 | 0 | |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | M | 0.00 | 31,250 | 0 | 314,255 | 283 K to 314.3 K (+11.04 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 0 | |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 0.00 | 18,750 | 0 | 84,416 | 65.7 K to 84.4 K (+28.55 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | M | 0.00 | 21,875 | 0 | 0 | |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Buy | M | 0.00 | 21,875 | 0 | 148,209 | 126.3 K to 148.2 K (+17.32 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Buy | M | 0.00 | 12,500 | 0 | 50,000 | 37.5 K to 50 K (+33.33 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | M | 0.00 | 6,250 | 0 | 0 | |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Buy | M | 0.00 | 6,250 | 0 | 42,000 | 35.8 K to 42 K (+17.48 %) |
| Jun 18 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.62 | 1,000,000 | 618,000 | 24,951,556 | 24 M to 25 M (+4.18 %) |
| Apr 24 2019 | VBIV | VBI Vaccines Inc/B ... | Cordeiro Joanne | Director | Option Exercise | A | 1.97 | 200,000 | 394,000 | 200,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Option Exercise | A | 1.64 | 200,000 | 328,000 | 200,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | McKee Blaine H. | Director | Option Exercise | A | 1.67 | 300,000 | 501,000 | 300,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 1.67 | 300,000 | 501,000 | 300,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Option Exercise | A | 1.64 | 300,000 | 492,000 | 300,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | A | 1.67 | 450,000 | 751,500 | 450,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Grant | A | 0.00 | 50,000 | 0 | 283,005 | 233 K to 283 K (+21.46 %) |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | A | 1.67 | 200,000 | 334,000 | 200,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Option Exercise | A | 1.67 | 300,000 | 501,000 | 300,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Option Exercise | A | 1.67 | 200,000 | 334,000 | 200,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Mazaltov Avi | Head Global MFG&GM- ... | Grant | A | 0.00 | 90,000 | 0 | 196,000 | 106 K to 196 K (+84.91 %) |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | A | 1.67 | 300,000 | 501,000 | 300,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Grant | A | 0.00 | 25,000 | 0 | 126,334 | 101.3 K to 126.3 K (+24.67 %) |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | A | 1.67 | 300,000 | 501,000 | 300,000 | |
| Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Grant | A | 0.00 | 15,000 | 0 | 35,750 | 20.8 K to 35.8 K (+72.29 %) |
| Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 185,714 | 260,000 | 185,714 | 0 to 185.7 K |
| Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 331,429 | 464,001 | 943,451 | 612 K to 943.5 K (+54.15 %) |
| Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 298,431 | 417,803 | 849,520 | 551.1 K to 849.5 K (+54.15 %) |
| Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 612,997 | 858,196 | 1,744,969 | 1.1 M to 1.7 M (+54.15 %) |
| Dec 17 2018 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.40 | 14,285,714 | 20,000,000 | 23,631,439 | 9.3 M to 23.6 M (+152.86 %) |
| Sep 21 2018 | VBIV | VBI Vaccines Inc/B ... | McNulty Christopher | CFO and Head of BD | Option Exercise | A | 1.83 | 250,000 | 457,500 | 250,000 | |
| Aug 07 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 1.93 | 8,100 | 15,607 | 233,005 | 224.9 K to 233 K (+3.60 %) |
| Aug 07 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 1.93 | 8,100 | 15,607 | 233,005 | 224.9 K to 233 K (+3.60 %) |
| Aug 06 2018 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 2.10 | 6,000 | 12,600 | 17,500 | 11.5 K to 17.5 K (+52.17 %) |
| Aug 06 2018 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 2.20 | 3,000 | 6,600 | 11,500 | 8.5 K to 11.5 K (+35.29 %) |
| Aug 06 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 2.01 | 13,500 | 27,111 | 224,905 | 211.4 K to 224.9 K (+6.39 %) |
| Aug 03 2018 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Buy | P | 2.01 | 2,000 | 4,011 | 20,750 | 18.8 K to 20.8 K (+10.67 %) |
| Aug 01 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 2.28 | 16,800 | 38,237 | 211,405 | 194.6 K to 211.4 K (+8.63 %) |
| Jun 25 2018 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
| Jun 25 2018 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 0.00 | 18,750 | 0 | 65,666 | 46.9 K to 65.7 K (+39.97 %) |
| Jun 20 2018 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jun 20 2018 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Buy | M | 0.00 | 18,750 | 0 | 56,250 | 37.5 K to 56.3 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | M | 0.00 | 21,875 | 0 | 21,875 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Payment of Exercise | F | 3.76 | 9,306 | 34,991 | 101,309 | 110.6 K to 101.3 K (-8.41 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Buy | M | 0.00 | 21,875 | 0 | 110,615 | 88.7 K to 110.6 K (+24.65 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Buy | M | 0.00 | 6,250 | 0 | 18,750 | 12.5 K to 18.8 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | M | 0.00 | 31,250 | 0 | 31,250 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | M | 0.00 | 31,250 | 0 | 194,605 | 163.4 K to 194.6 K (+19.13 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 18,750 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Buy | M | 0.00 | 18,750 | 0 | 56,250 | 37.5 K to 56.3 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | M | 0.00 | 21,875 | 0 | 21,875 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Payment of Exercise | F | 3.76 | 9,306 | 34,991 | 101,309 | 110.6 K to 101.3 K (-8.41 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Buy | M | 0.00 | 21,875 | 0 | 110,615 | 88.7 K to 110.6 K (+24.65 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Buy | M | 0.00 | 6,250 | 0 | 18,750 | 12.5 K to 18.8 K (+50.00 %) |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | M | 0.00 | 31,250 | 0 | 31,250 | |
| Jun 18 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | M | 0.00 | 31,250 | 0 | 194,605 | 163.4 K to 194.6 K (+19.13 %) |
| May 25 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 2.99 | 11,000 | 32,890 | 163,355 | 152.4 K to 163.4 K (+7.22 %) |
| May 14 2018 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 3.13 | 4,500 | 14,085 | 268,839 | 264.3 K to 268.8 K (+1.70 %) |
| May 14 2018 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 2.98 | 5,500 | 16,390 | 8,500 | 3 K to 8.5 K (+183.33 %) |
| May 14 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 2.91 | 7,100 | 20,661 | 152,355 | 145.3 K to 152.4 K (+4.89 %) |
| Feb 06 2018 | VBIV | VBI Vaccines Inc/B ... | Kartsaklis Athena | SVP Finance, CCO | Option Exercise | A | 4.26 | 75,000 | 319,125 | 75,000 | |
| Jan 30 2018 | VBIV | VBI Vaccines Inc/B ... | Mazaltov Avi | Head Global MFG&GM- ... | Option Exercise | A | 4.19 | 100,000 | 419,000 | 100,000 | |
| Jan 29 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
| Jan 26 2018 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | A | 4.19 | 100,000 | 419,000 | 100,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Logal Adam | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Option Exercise | A | 4.26 | 100,000 | 425,500 | 100,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Buckley T. Adam | VP, Business Develo ... | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Anderson David Evander | Chief Scientific Of ... | Option Exercise | A | 4.19 | 100,000 | 419,000 | 100,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Beattie Nell | Chief Business Offi ... | Option Exercise | A | 4.19 | 100,000 | 419,000 | 100,000 | |
| Jan 25 2018 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Option Exercise | A | 4.19 | 150,000 | 628,500 | 150,000 | |
| Dec 13 2017 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 3.88 | 4,609 | 17,883 | 145,255 | 140.6 K to 145.3 K (+3.28 %) |
| Dec 13 2017 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 3.89 | 5,391 | 20,971 | 140,646 | 135.3 K to 140.6 K (+3.99 %) |
| Nov 29 2017 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 4.75 | 15,000 | 71,250 | 135,255 | 120.3 K to 135.3 K (+12.47 %) |
| Nov 01 2017 | VBIV | VBI Vaccines Inc/B ... | Opko Health, Inc. | 10% Owner | Buy | P | 3.05 | 655,738 | 2,000,001 | 6,678,752 | 6 M to 6.7 M (+10.89 %) |
| Oct 31 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | P | 3.05 | 300,000 | 915,000 | 3,026,057 | 2.7 M to 3 M (+11.00 %) |
| Oct 31 2017 | VBIV | VBI Vaccines Inc/B ... | CHAWLA SAM | Director | Buy | P | 3.05 | 3,100,000 | 9,455,000 | 9,345,725 | 6.2 M to 9.3 M (+49.63 %) |
| Oct 30 2017 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.05 | 3,100,000 | 9,455,000 | 9,345,725 | 6.2 M to 9.3 M (+49.63 %) |
| Aug 22 2017 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Buy | P | 3.17 | 3,000 | 9,510 | 3,000 | 0 to 3 K |
| Aug 22 2017 | VBIV | VBI Vaccines Inc/B ... | Baxter Jeff | CEO, President | Buy | P | 3.22 | 10,000 | 32,200 | 120,255 | 110.3 K to 120.3 K (+9.07 %) |
| Jun 23 2017 | VBIV | VBI Vaccines Inc/B ... | Diaz-Mitoma Francisco | Chief Medical Offic ... | Grant | A | 0.00 | 12,500 | 0 | 264,339 | 251.8 K to 264.3 K (+4.96 %) |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | DeWilde Michel | Director | Buy | M | 0.00 | 12,500 | 0 | 25,000 | 12.5 K to 25 K (+100.00 %) |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Buckley T. Adam | VP, Business Develo ... | Option Exercise | M | 0.00 | 4,687 | 0 | 9,374 | |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Buckley T. Adam | VP, Business Develo ... | Buy | M | 0.00 | 4,687 | 0 | 44,063 | 39.4 K to 44.1 K (+11.90 %) |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | GILLIS STEVEN | Director | Buy | M | 0.00 | 18,750 | 0 | 46,916 | 28.2 K to 46.9 K (+66.57 %) |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Option Exercise | M | 0.00 | 18,750 | 0 | 37,500 | |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Rubin Steven D | Director | Buy | M | 0.00 | 18,750 | 0 | 37,500 | 18.8 K to 37.5 K (+100.00 %) |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
| Jun 16 2017 | VBIV | VBI Vaccines Inc/B ... | Requadt Scott | Director | Buy | M | 0.00 | 12,500 | 0 | 25,000 | 12.5 K to 25 K (+100.00 %) |